Clearstead Advisors, LLC Trans Medics Group, Inc. Transaction History
Clearstead Advisors, LLC
- $2.01 Billion
- Q1 2024
A detailed history of Clearstead Advisors, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 150 shares of TMDX stock, worth $22,429. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$22,429
Previous $11,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TMDX
# of Institutions
283Shares Held
28.8MCall Options Held
338KPut Options Held
370K-
Black Rock Inc. New York, NY2.52MShares$377 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$282 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C31.3MShares$194 Million0.11% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.28MShares$192 Million1.04% of portfolio
-
Invesco Ltd. Atlanta, GA1.28MShares$192 Million0.02% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $4.76B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...